Debeuf Nincy, Lameire Sahine, Vanheerswynghels Manon, Deckers Julie, De Wolf Caroline, Toussaint Wendy, Verbeke Rein, Verstaen Kevin, Hammad Hamida, Vanhee Stijn, Lambrecht Bart N
Laboratory of Immunoregulation and Mucosal Immunology, VIB Center for Inflammation Research, Ghent, Belgium.
Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
Elife. 2024 Dec 30;13:RP98344. doi: 10.7554/eLife.98344.
Since the precursor frequency of naive T cells is extremely low, investigating the early steps of antigen-specific T cell activation is challenging. To overcome this detection problem, adoptive transfer of a cohort of T cells purified from T cell receptor (TCR) transgenic donors has been extensively used but is not readily available for emerging pathogens. Constructing TCR transgenic mice from T cell hybridomas is a labor-intensive and sometimes erratic process, since the best clones are selected based on antigen-induced CD69 upregulation or IL-2 production in vitro, and TCR chains are polymerase chain reaction (PCR)-cloned into expression vectors. Here, we exploited the rapid advances in single-cell sequencing and TCR repertoire analysis to select the best clones without hybridoma selection, and generated CORSET8 mice (ona pike pitope specific CD8 cell), carrying a TCR specific for the Spike protein of SARS-CoV-2. Implementing newly created DALI software for TCR repertoire analysis in single-cell analysis enabled the rapid selection of the ideal responder CD8 T cell clone, based on antigen reactivity, proliferation, and immunophenotype in vivo. Identified TCR sequences were inserted as synthetic DNA into an expression vector and transgenic CORSET8 donor mice were created. After immunization with Spike/CpG-motifs, mRNA vaccination or SARS-CoV-2 infection, CORSET8 T cells strongly proliferated and showed signs of T cell activation. Thus, a combination of TCR repertoire analysis and scRNA immunophenotyping allowed rapid selection of antigen-specific TCR sequences that can be used to generate TCR transgenic mice.
由于初始T细胞的前体频率极低,研究抗原特异性T细胞激活的早期步骤具有挑战性。为了克服这一检测问题,从T细胞受体(TCR)转基因供体中纯化一批T细胞进行过继转移已被广泛应用,但对于新出现的病原体来说并不容易获得。从T细胞杂交瘤构建TCR转基因小鼠是一个劳动密集型且有时不稳定的过程,因为最佳克隆是根据体外抗原诱导的CD69上调或IL-2产生来选择的,并且TCR链通过聚合酶链反应(PCR)克隆到表达载体中。在这里,我们利用单细胞测序和TCR库分析的快速进展,无需杂交瘤选择即可选择最佳克隆,并生成了CORSET8小鼠(针对刺突表位特异性CD8细胞),其携带针对SARS-CoV-2刺突蛋白的TCR。在单细胞分析中实施新创建的DALI软件进行TCR库分析,能够根据体内的抗原反应性、增殖和免疫表型快速选择理想的反应性CD8 T细胞克隆。将鉴定出的TCR序列作为合成DNA插入表达载体,创建了转基因CORSET8供体小鼠。在用刺突/CpG基序、mRNA疫苗接种或SARS-CoV-2感染免疫后,CORSET8 T细胞强烈增殖并显示出T细胞激活的迹象。因此,TCR库分析和scRNA免疫表型分析相结合,能够快速选择可用于生成TCR转基因小鼠的抗原特异性TCR序列。